Zobrazeno 1 - 10
of 419
pro vyhledávání: '"Gaffey S"'
Autor:
Rahman R; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Trippa L; Dana-Farber Cancer Institute, Boston, MA., Lee EQ; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Arrillaga-Romany I; Massachusetts General Hospital, Boston, MA., Fell G; Dana-Farber Cancer Institute, Boston, MA., Touat M; Brigham and Women's Hospital, Boston, MA.; Sorbonne Universite, Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France., McCluskey C; Dana-Farber Cancer Institute, Boston, MA., Wiley J; Dana-Farber Cancer Institute, Boston, MA., Gaffey S; Dana-Farber Cancer Institute, Boston, MA., Drappatz J; University of Pittsburgh, Pittsburgh, PA., Welch MR; Division of Neuro-Oncology, Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian, New York, NY., Galanis E; Mayo Clinic, Rochester, MN., Ahluwalia MS; Miami Cancer Institute, Miami, FL., Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Nabors LB; University of Alabama at Birmingham, Birmingham, AL., Hepel J; Rhode Island Hospital, Providence, RI., Elinzano H; Rhode Island Hospital, Providence, RI., Schiff D; University of Virginia, Charlottesville, VA., Chukwueke UN; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Beroukhim R; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Nayak L; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., McFaline-Figueroa JR; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Batchelor TT; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Rinne ML; Dana-Farber Cancer Institute, Boston, MA., Kaley TJ; Memorial Sloan Kettering Cancer Center, New York, NY., Lu-Emerson C; Maine Medical Center, Portland, ME., Mellinghoff IK; Memorial Sloan Kettering Cancer Center, New York, NY., Bi WL; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Arnaout O; Brigham and Women's Hospital, Boston, MA., Peruzzi PP; Brigham and Women's Hospital, Boston, MA., Haas-Kogan D; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Tanguturi S; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Cagney D; Mater Private, Dublin, Ireland., Aizer A; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Doherty L; Dana-Farber Cancer Institute, Boston, MA., Lavallee M; Dana-Farber Cancer Institute, Boston, MA., Fisher-Longden B; Dana-Farber Cancer Institute, Boston, MA., Dowling S; Dana-Farber Cancer Institute, Boston, MA., Geduldig J; Dana-Farber Cancer Institute, Boston, MA., Watkinson F; Dana-Farber Cancer Institute, Boston, MA., Pisano W; Dana-Farber Cancer Institute, Boston, MA., Malinowski S; Dana-Farber Cancer Institute, Boston, MA., Ramkissoon S; Dana-Farber Cancer Institute, Boston, MA., Santagata S; Brigham and Women's Hospital, Boston, MA., Meredith DM; Brigham and Women's Hospital, Boston, MA., Chiocca EA; Brigham and Women's Hospital, Boston, MA., Reardon DA; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Alexander BM; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Ligon KL; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Wen PY; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 20; Vol. 41 (36), pp. 5524-5535. Date of Electronic Publication: 2023 Sep 18.
Autor:
Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Standifer N; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, South San Francisco, California., Dietrich J; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts., Clarke JL; Departments of Neurology and Neurosurgery, University of California, San Francisco, San Francisco, California., Dunn GP; Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri., Lim M; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland., Cloughesy T; Department of Neurology, University of California, Los Angeles, Los Angeles, California., Gan HK; Department of Medical Oncology, Austin Health, Melbourne, Australia., Flagg E; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts., George E; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Gaffey S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hayden J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Holcroft C; PROMETRIKA, LLC, New York, New York., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Macri M; Ludwig Cancer Research, New York, New York., Park AJ; Ludwig Cancer Research, New York, New York., Ricciardi T; Ludwig Cancer Research, New York, New York., Ryan A; Ludwig Cancer Research, New York, New York., Schwarzenberger P; Ludwig Cancer Research, New York, New York., Venhaus R; Ludwig Cancer Research, New York, New York., Reyes ML; Translational Medicine Oncology, Early and Early Oncology, R&D, Gaithersburg, Maryland., Durham NM; Translational Medicine Oncology, Early and Early Oncology, R&D, Gaithersburg, Maryland., Creasy T; Translational Medicine Oncology, Early and Early Oncology, R&D, Gaithersburg, Maryland., Huang RY; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts., Kaley T; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jun 13; Vol. 28 (12), pp. 2567-2578.
Autor:
Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Meredith DM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Driver J; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Du Z; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China., Hoffman S; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Rinne M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., McFaline-Figueroa R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., McCluskey C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gaffey S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Stefanik J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Doherty L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Taubert C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cifrino M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., LaFrankie D; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Graillon T; Faculté de Médecine, Aix Marseille Université, Marseille, France., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ligon KL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Al-Mefty O; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Huang RY; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Muzikansky A; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Dunn IF; Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2022 Jan 05; Vol. 24 (1), pp. 101-113.
Autor:
Nayak L; Dana-Farber Cancer Institute, Boston, Massachusetts., Molinaro AM; University of California San Francisco, San Francisco, California., Peters K; Duke University Medical Center, Durham, North Carolina., Clarke JL; University of California San Francisco, San Francisco, California., Jordan JT; Massachusetts General Hospital, Boston, Massachusetts., de Groot J; M.D. Anderson Cancer Center, Houston, Texas., Nghiemphu L; University of California, Los Angeles, Los Angeles, California., Kaley T; Memorial Sloan Kettering Cancer Center, New York City, New York., Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., McCluskey C; Dana-Farber Cancer Institute, Boston, Massachusetts., Gaffey S; Dana-Farber Cancer Institute, Boston, Massachusetts., Smith TR; Brigham and Women's Hospital, Boston, Massachusetts., Cote DJ; Brigham and Women's Hospital, Boston, Massachusetts., Severgnini M; Dana-Farber Cancer Institute, Boston, Massachusetts., Yearley JH; Merck & Co., Inc., Kenilworth, New Jersey., Zhao Q; Merck & Co., Inc., Kenilworth, New Jersey., Blumenschein WM; Merck & Co., Inc., Kenilworth, New Jersey., Duda DG; Massachusetts General Hospital, Boston, Massachusetts., Muzikansky A; Massachusetts General Hospital, Boston, Massachusetts., Jain RK; Massachusetts General Hospital, Boston, Massachusetts., Wen PY; Dana-Farber Cancer Institute, Boston, Massachusetts., Reardon DA; Dana-Farber Cancer Institute, Boston, Massachusetts. david_reardon@dfci.harvard.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Feb 15; Vol. 27 (4), pp. 1048-1057. Date of Electronic Publication: 2020 Nov 16.
Autor:
Valerius, Allison R.1 (AUTHOR) sener.ugur@mayo.edu, Webb, Lauren M.1 (AUTHOR), Thomsen, Anna1 (AUTHOR), Lehrer, Eric J.2 (AUTHOR), Breen, William G.2 (AUTHOR), Campian, Jian L.3 (AUTHOR), Riviere-Cazaux, Cecile4 (AUTHOR), Burns, Terry C.4 (AUTHOR), Sener, Ugur1,3 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10570. 28p.
Autor:
Beck, Pierre1 (AUTHOR) pierre.beck@univ-grenoble-alpes.fr, Beyssac, Olivier2 (AUTHOR), Schmitt, Bernard1 (AUTHOR), Royer, Clement3 (AUTHOR), Mandon, Lucia1 (AUTHOR), Boulard, Eglantine2 (AUTHOR), Rividi, Nicolas2 (AUTHOR), Cloutis, Edward A.4 (AUTHOR)
Publikováno v:
Earth & Space Science. Sep2024, Vol. 11 Issue 9, p1-16. 16p.
Autor:
Lee EQ; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Muzikansky A; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts., Duda DG; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts., Gaffey S; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Dietrich J; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts., Nayak L; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Chukwueke UN; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Beroukhim R; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Doherty L; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Laub CK; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., LaFrankie D; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Fontana B; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Stefanik J; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Ruland S; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Caruso V; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Bruno J; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Ligon K; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Reardon DA; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Wen PY; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer medicine [Cancer Med] 2019 Oct; Vol. 8 (13), pp. 5988-5994. Date of Electronic Publication: 2019 Aug 24.
Autor:
Lee EQ; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Chukwueke UN; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Hervey-Jumper SL; University of California San Francisco, San Francisco, California, USA., de Groot JF; MD Anderson Cancer Center, Houston, Texas, USA., Leone JP; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Chang SM; University of California San Francisco, San Francisco, California, USA., Arons D; National Brain Tumor Society, Newton, Massachusetts, USA., Oliver K; International Brain Tumour Alliance, Tadworth, Surrey, UK., Verble K; The Sontag Foundation and Brain Tumor Network, Ponte Vedre Beach, Florida, USA., Musella A; The Musella Foundation for Brain Tumor Research and Information, Hewlett, New York, USA., Willmarth N; American Brain Tumor Association, Chicago, Illinois, USA., Alexander BM; Foundation Medicine, Cambridge, Massachusetts, USA., Bates A; National Brain Tumor Society, Newton, Massachusetts, USA., Doherty L; National Brain Tumor Society, Newton, Massachusetts, USA., Galanis E; Mayo Clinic, Rochester, Minnesota, USA., Gaffey S; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Halkin T; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Friday BE; Essentia Health, Duluth, Minnesota, USA., Fouladi M; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Lin NU; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Macdonald D; University of Western Ontario, London, Ontario, Canada., Mehta MP; Miami Cancer Institute, Miami, Florida, USA., Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Vogelbaum MA; Moffitt Cancer Center, Tampa, Florida, USA., Sahebjam S; Moffitt Cancer Center, Tampa, Florida, USA., Sandak D; Accelerate Brain Cancer Cure (ABC2), Washington, DC, USA., van den Bent M; Erasmus University Hospital, Rotterdam, Netherlands., Weller M; University Hospital and University of Zurich, Zurich, Switzerland., Reardon DA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wen PY; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2019 Sep 06; Vol. 21 (9), pp. 1100-1117.
Autor:
Alexander BM; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Trippa L; Dana-Farber Cancer Institute, Boston, MA., Gaffey S; Dana-Farber Cancer Institute, Boston, MA., Arrillaga-Romany IC; Massachusetts General Hospital, Boston, MA., Lee EQ; Dana-Farber Cancer Institute, Boston, MA., Rinne ML; Brigham and Women's Hospital, Boston, MA.; Novartis Institutes for Biomedical Research, Boston, MA., Ahluwalia MS; Cleveland Clinic, Cleveland, OH., Colman H; Huntsman Cancer Institute, Salt Lake City, UT., Fell G; Dana-Farber Cancer Institute, Boston, MA., Galanis E; Mayo Clinic, Rochester, MN., de Groot J; MD Anderson Cancer Center, Houston, TX., Drappatz J; University of Pittsburgh Medical Center, Pittsburgh, PA., Lassman AB; Columbia University Medical Center, New York, NY., Meredith DM; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Nabors LB; University of Alabama at Birmingham, Birmingham, AL., Santagata S; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Schiff D; University of Virginia Health System, Charlottesville, VA., Welch MR; Columbia University Medical Center, New York, NY., Ligon KL; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA., Wen PY; Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2019 Mar 27; Vol. 3. Date of Electronic Publication: 2019 Mar 27 (Print Publication: 2019).
Autor:
Zhao C; Department of Pharmacy, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, People's Republic of China., Zeng Y; Department of Clinical Pharmacology and Bioanalytics, Pfizer (China) Research and Development Co., Ltd., Shanghai, People's Republic of China., Kang N; School of Life Science & Technology, China Pharmaceutical University, Nanjing, People's Republic of China., Liu Y; School of Life Science & Technology, China Pharmaceutical University, Nanjing, People's Republic of China.
Publikováno v:
Drug development research [Drug Dev Res] 2024 Sep; Vol. 85 (6), pp. e22257.